Hinge Health Inc. (NYSE:HNGE) Receives Average Recommendation of "Moderate Buy" from Brokerages

Key Points

• Consensus "Moderate Buy": Nineteen analysts cover Hinge Health with an aggregate recommendation of Moderate Buy (16 buys, 1 strong buy, 1 hold, 1 sell) and an average one-year price target of about $56.73, with some targets as high as $68.
• Quarterly beat and fast revenue growth: Hinge Health reported Q4 EPS of $0.49 vs. $0.04 expected and revenue of $170.7M (up 45.5% year‑over‑year), beating analyst estimates on both measures.
• Insider selling amid heavy institutional accumulation: Insiders sold 409,337 shares (~$17.3M) in the last 90 days (including the CEO), while major institutions like BIT Capital, Vanguard, Tiger Global and Millennium substantially increased their stakes in Q4.

Hinge Health Inc. (NYSE:HNGE - Get Free Report) has been given a consensus recommendation of "Moderate Buy" by the nineteen research firms that are presently covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation, sixteen have given a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1 year price objective among brokerages that have issued a report on the stock in the last year is $56.7333.

A number of research firms recently weighed in on HNGE. Wall Street Zen upgraded shares of Hinge Health from a "hold" rating to a "buy" rating in a research note on Saturday, March 7th. Stifel Nicolaus set a $59.00 price target on shares of Hinge Health in a report on Thursday, February 5th. KeyCorp set a $55.00 price target on shares of Hinge Health in a report on Wednesday, February 11th. Royal Bank Of Canada lifted their price target on shares of Hinge Health from $50.00 to $55.00 and gave the company an "outperform" rating in a report on Wednesday, March 11th. Finally, Wells Fargo & Company assumed coverage on shares of Hinge Health in a report on Thursday, January 8th. They issued an "overweight" rating and a $68.00 price target on the stock.

Insider Activity at Hinge Health

In other Hinge Health news, President James Pursley sold 15,000 shares of Hinge Health stock in a transaction on Monday, March 23rd. The shares were sold at an average price of $42.26, for a total value of $633,900.00. Following the sale, the president directly owned 732,104 shares in the company, valued at approximately $30,938,715.04. The trade was a 2.01% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Daniel Antonio Perez sold 166,665 shares of Hinge Health stock in a transaction on Thursday, February 12th. The shares were sold at an average price of $40.26, for a total transaction of $6,709,932.90. The SEC filing for this sale provides additional information. In the last 90 days, insiders have sold 409,337 shares of company stock valued at $17,285,250.

Institutional Trading of Hinge Health

A number of institutional investors and hedge funds have recently bought and sold shares of HNGE. BIT Capital GmbH increased its holdings in Hinge Health by 79.3% in the 4th quarter. BIT Capital GmbH now owns 3,316,101 shares of the company's stock valued at $154,033,000 after acquiring an additional 1,466,577 shares during the last quarter. Vanguard Group Inc. increased its holdings in shares of Hinge Health by 110.5% in the 4th quarter. Vanguard Group Inc. now owns 2,605,532 shares of the company's stock worth $121,027,000 after buying an additional 1,367,693 shares during the last quarter. Tiger Global Management LLC increased its holdings in shares of Hinge Health by 227.1% in the 4th quarter. Tiger Global Management LLC now owns 1,805,751 shares of the company's stock worth $83,877,000 after buying an additional 1,253,743 shares during the last quarter. Marshall Wace LLP bought a new stake in shares of Hinge Health in the 4th quarter worth about $54,469,000. Finally, Millennium Management LLC increased its holdings in shares of Hinge Health by 225.0% in the 4th quarter. Millennium Management LLC now owns 1,479,642 shares of the company's stock worth $68,729,000 after buying an additional 1,024,317 shares during the last quarter.

Hinge Health Stock Performance

HNGE opened at $35.39 on Friday. Hinge Health has a fifty-two week low of $30.08 and a fifty-two week high of $62.18. The firm's fifty day moving average is $40.12 and its 200 day moving average is $44.76. The stock has a market cap of $2.79 billion and a price-to-earnings ratio of -2.76.

Hinge Health (NYSE:HNGE - Get Free Report) last released its earnings results on Tuesday, February 10th. The company reported $0.49 earnings per share for the quarter, beating analysts' consensus estimates of $0.04 by $0.45. The firm had revenue of $170.73 million for the quarter, compared to analysts' expectations of $157.31 million. The business's revenue for the quarter was up 45.5% on a year-over-year basis.

Hinge Health Company Profile

Hinge Health NYSE: HNGE is a digital musculoskeletal (MSK) clinic that provides end-to-end solutions for the prevention and management of musculoskeletal conditions. The company's platform combines wearable motion sensors, personalized exercise therapy guided by licensed physical therapists, and behavioral health coaching to deliver tailored treatment plans. By integrating technology with evidence-based clinical protocols, Hinge Health aims to reduce pain, improve mobility and decrease reliance on more invasive interventions such as surgery or opioid prescriptions.

Founded in 2015 and headquartered in San Francisco, Hinge Health partners with employers, health plans and other payers to offer its self-directed, app-based programs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.